Recent Finacing
Recent Raise
Biolexis Therapeutics is a clinical-stage biopharma using MolecuLern, an AI-enabled process, to identify small-molecule drug candidates for oncology, immune, neurodegenerative, metabolic, and inflammatory indications; ~40 discovery and 10 IND-stage programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor